Veraxa Biotech is trading at $1.85, down 5% today, as the stock faces downward pressure alongside the broader biotech sector and cautious market sentiment.
- No fresh company-specific headlines, regulatory filings, or analyst calls have been released this morning to account for the decline.
- The move appears to be driven by macro-level sector pressure rather than a new, stock-specific catalyst.